✦ LIBER ✦

Neoadjuvant chemotherapy with HER2 inhibitors for breast cancer – Authors' reply

✍ Scribed by José Baselga; Evandro de Azambuja; Ian Bradbury; Richard Gelber

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant chemotherapy with HER2 inhib

✍ Tetsuji Fujita 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 68 KB

Neoadjuvant chemotherapy with HER2 inhib

✍ Katya Brede-Hekimian 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 68 KB

HER-2 expression after neoadjuvant chemo

✍ Yaojun Feng; Xinhong Wu; Cuiping Pan; Juan Xu; Wei Zhong; Jun Shao; Biao Ma 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 241 KB

Prognostic Factors for Locoregional Recu

✍ D.M. Arsenault; J. Hurley; I. Reis; W. Zhao; C. Takita; C. Gomez; M. Jorda; M. C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Discordances in ER, PR and HER2 receptor

✍ S. van de Ven; V.T.H.B.M. Smit; T.J.A. Dekker; J.W.R. Nortier; J.R. Kroep 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 200 KB

Immunohistochemical expression of HER1,

✍ Kan Yonemori; Koji Tsuta; Chikako Shimizu; Yutaka Hatanaka; Akihiro Hirakawa; Ma 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views